Deprescribing Proton Pump Inhibitors in an Academic, Primary Care Clinic Quality Improvement Project

被引:14
|
作者
Nallapeta, Naren [1 ]
Reynolds, Jessica L. [2 ]
Bakhai, Smita [3 ]
机构
[1] Univ Buffalo State Univ New York, Dept Internal Med, Buffalo, NY 14215 USA
[2] Univ Buffalo State Univ New York, Dept Med, Buffalo, NY 14215 USA
[3] Univ Buffalo State Univ New York, ECMC, Dept Internal Med, Suite 15,462 Grider St, Buffalo, NY 14215 USA
基金
美国国家卫生研究院;
关键词
proton pump inhibitors; quality improvement; evidence-based guidelines; deprescribing PPI; primary care; inappropriate use of PPI; COMMUNITY-ACQUIRED PNEUMONIA; LONG-TERM USE; RISK; THERAPY; INFECTION; BENEFITS; OVERUSE; NEED;
D O I
10.1097/MCG.0000000000001317
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Goal: The goal of this study was to reduce the percentage of inappropriately prescribed proton pump inhibitors (PPIs) in patients aged 50 and older from 80% (baseline) to 60% within 12 months in an academic, internal medicine clinic. Background: The use of PPIs has increased drastically worldwide. Internal medicine clinic patients had inappropriate use of PPIs for an average of 4 to 5 years. Study: A multidisciplinary quality improvement team used the Plan-Do-Study-Act Model of health care improvement and performed a root cause analysis to identify barriers to inappropriate use of PPIs. The outcome measure was the percentage of patients inappropriately prescribed PPI. Process measures were completion rates of PPI risk assessment and esophagogastroduodenoscopy. Interventions included the creation of customized electronic health record templates and education to providers and patients. Analysis was performed using monthly statistical process control charts. Results: The average rate of PPI discontinuation was 51.1% (n=92/180), which corresponds to 30.0% inappropriate PPI usage within 12 months. The mean PPI discontinuation rate in the 1-year prestudy, study and 6 months poststudy period was 2.0%, 32.0%, and 49.7%, respectively. The mean esophagogastroduodenoscopy completion rate was 49.8% from the baseline of Conclusions: We achieved a statistically significant and sustainable reduction of inappropriate PPI use to 30% from the baseline rates of 80% and surpassed our goal within 12 months. This quality improvement was unique as no pharmacy personnel was utilized in this process. The multifaceted strategies in a safety-net internal medicine clinic resulted in successful deprescribing of PPI and can be replicated in other setting.
引用
收藏
页码:864 / 870
页数:7
相关论文
共 50 条
  • [1] Successful deprescribing of unnecessary proton pump inhibitors in a primary care clinic
    Odenthal, Danielle R.
    Philbrick, Ann M.
    Harris, Ila M.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (01) : 100 - 104
  • [2] Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project
    Calvo, Lamuela L. J.
    Garcia Camara, P.
    Llorente Barrio, M.
    Sierra Gabarda, O.
    Monzon Baez, R.
    Arbones Mainar, J. M.
    Alcedo Gonzalez, J.
    Bernal Monterde, V
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (12) : 1927 - 1933
  • [3] Problems Associated with Deprescribing of Proton Pump Inhibitors
    Helgadottir, Holmfridur
    Bjornsson, Einar S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [4] The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing
    Dharmarajan, Thiruvinvamalai S.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2021, 22 (01) : 15 - 22
  • [5] Deprescribing proton pump inhibitors
    Turner, Justin P.
    Thompson, Wade
    Reeve, Emily
    Bell, J. Simon
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (11) : 845 - 848
  • [6] Deprescribing proton pump inhibitors
    Teh, Kim Jun Kevin
    Puar, Hai Kiat Troy
    How, Choon How
    Tan, Teck Kiang Malcolm
    SINGAPORE MEDICAL JOURNAL, 2023, 64 (08) : 503 - 507
  • [7] Deprescribing strategies for proton pump inhibitors
    Young, Julia
    Fuller, Jordan A.
    Guidry, Corey M.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2024, 37 (11): : 51 - 51
  • [8] Deprescribing proton pump inhibitors: why, when and how
    Bytzer, Peter
    MEDICAL JOURNAL OF AUSTRALIA, 2018, 209 (10) : 436 - +
  • [9] Patient and Provider Perspectives on Deprescribing Proton Pump Inhibitors
    Ikeji, Chisom
    Williams, Anne
    Hennawi, George
    Brandt, Nicole J.
    JOURNAL OF GERONTOLOGICAL NURSING, 2019, 45 (10): : 9 - 17
  • [10] Evidence-based deprescribing of proton pump inhibitors in long-term care
    Sluggett, Janet K.
    Hendrix, Ivanka
    Bell, J. Simon
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (02): : 124 - 126